Enstilar Aerosol, Foam
Product Images NDC 50222-302
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Enstilar (NDC 50222-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Leo Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Enstilar 02
Enstilar 03
Enstilar 04
Enstilar 05
Enstilar 06
Enstilar 07
Enstilar 08
Enstilar Foam with Calcipotriene and Betamethasone Dipropionate is a topical medication used to treat skin conditions such as psoriasis. It is a flammable product that should be kept away from heat, sparks, and open flames. The product comes in a container filled with foam that needs to be shaken before use. The recommended storage temperature is between 20-25°C, and it should not be exposed to temperatures above 45°C or below 15°C. The medication should not be used for oral, ophthalmic, or intravaginal use. The dosage information needs to be obtained from a prescribing physician. The product is manufactured by LEO Laboratories Ltd. and distributed by LEO Pharma Inc. in Madison, USA.*
Enstilar 09
Enstilar® is a foam medication for topical use only containing calcipotriene and betamethasone. The medication is dispensed in 2 cans of 60 grams each, with a net weight of 120 grams. Shake before use and keep out of reach of children. Not for oral, ophthalmic, or intravaginal use. Dosage should be prescribed by a healthcare professional.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.